Cerevel Therapeutics Holdings, Inc. (CERE)

NASDAQ: CERE · IEX Real-Time Price · USD

42.55

-0.04 (-0.09%)

At close: May 3, 2024, 4:00 PM

42.61

+0.06 (0.15%)

After-hours: May 3, 2024, 5:47 PM EDT

CERE Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	418.43	138.39	197.22	387.82	83.68
Short-Term Investments	574.5	755.51	372.67	0	0
Cash & Cash Equivalents	992.93	893.9	569.89	387.82	83.68
Cash Growth	11.08%	56.85%	46.95%	363.45%	-
Other Current Assets	14.01	11.75	8.13	2.74	3.4
Total Current Assets	1,007	905.65	578.02	390.56	87.08
Property, Plant & Equipment	45.77	49.29	51.7	48.62	27.49
Long-Term Investments	185.2	58.13	52.27	0	0
Other Long-Term Assets	5.39	4.76	6.93	6.09	6.24
Total Long-Term Assets	236.36	112.17	110.9	54.71	33.73
Total Assets	1,243	1,018	688.92	445.27	120.81
Accounts Payable	11.86	10.06	11.3	4.99	2.11
Current Debt	3.4	2.9	2.44	2.04	2.59
Other Current Liabilities	76.91	59.6	28.8	22.52	10.18
Total Current Liabilities	92.18	72.56	42.54	29.55	14.88
Long-Term Debt	477.37	424.02	67.65	30.97	25.82
Other Long-Term Liabilities	0	0	0	0.24	2.29
Total Long-Term Liabilities	477.37	424.02	67.65	31.21	28.11
Total Liabilities	569.55	496.58	110.19	60.75	42.98
Total Debt	480.78	426.92	70.09	33.01	28.41
Debt Growth	12.62%	509.13%	112.35%	16.17%	-
Retained Earnings	-1,400.6	-967.76	-616.24	-390.91	-244.3
Comprehensive Income	1.77	3.1	-0.99	0	0
Shareholders' Equity	673.75	521.24	578.73	384.52	77.82
Net Cash / Debt	512.15	466.98	499.8	354.82	55.27
Net Cash / Debt Growth	9.67%	-6.57%	40.86%	541.96%	-
Net Cash Per Share	3.16	3.09	3.66	4.82	1.25
Working Capital	914.76	833.09	535.48	361.01	72.2
Book Value Per Share	4.16	3.45	4.24	5.22	1.76

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).